Netherlands· NL-6cd9ab091aa6
Sorbisterit, poeder voor orale/rectale suspensie 90% m/m
A polystyrene sulfonate product containing polystyreensulfonaat calcium, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Polystyrene sulfonate is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AE01 (polystyrene sulfonate), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Polystyrene sulfonate · ATC V03AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of polystyrene sulfonate costs, country by country.
Normalised to the WHO defined daily dose (45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Polystyrene sulfonate · price per daily dose (45 g)
USD · FX 28 Sept 2026
- CZ Czechia$0.0074
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- POLYSTYREENSULFONAAT CALCIUM
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- V03AE01
- ATC class
- Polystyrene sulfonate
- Defined daily dose
- 45 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id118303//10261
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V03AE01
Polystyrene sulfonate, as other registers publish it.
- PolandCalcium ResoniumSanofi Winthrop Industrie
- IrelandCalcium Resonium 99.934% Powder for oral or rectal suspensionSanofi-Aventis Ireland Limited T/A SANOFI
- NetherlandsCalciumpolystyreensulfonaat 1 g/g Focus Care, poeder voor suspensie voor oraal/rectaal gebruikFocus Care Pharmaceuticals B.V.
- DenmarkCalciumpolystyrensulfonat CarefarmOrifarm A/S
- CanadaJAMP SODIUM POLYSTYRENE SULFONATEJAMP PHARMA CORPORATION
- CanadaKAYEXALATESANOFI-AVENTIS CANADA INC
- BelgiumKayexalate Calcium 14.99 gSanofi Belgium
- BelgiumKayexalate Sodium 14.99 gSanofi Belgium
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd79212e-0040-4e51-ba54-5305f7572651 GET /v1/drugs/cd79212e-0040-4e51-ba54-5305f7572651?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor suspensie voor rectaal gebruik, Poeder voor orale suspensie",
"route": "Oraal gebruik, Rectaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10261_smpc.pdf",
"strength": null,
"atc_label": "Polystyrene Sulfonate",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118303",
"excipients": [
"CITROENZUUR 0-WATER (E 330)",
"SACCHAROSE"
],
"substances": [
"POLYSTYREENSULFONAAT CALCIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118303.pdf",
"authorised_at": "2015/12/07",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "118303//10261",
"additional_monitoring": "N"
}See everything about polystyrene sulfonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.